DEUTSCHE BANK AG\ - ZEALAND PHARMA A S ownership

ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 18 filers reported holding ZEALAND PHARMA A S in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ZEALAND PHARMA A S
ValueSharesWeighting
Q4 2019$15,000
-25.0%
456
-62.0%
0.00%
Q1 2019$20,000
-91.2%
1,200
-91.3%
0.00%
Q3 2018$227,000
+363.3%
13,800
+430.8%
0.00%
Q3 2017$49,0002,6000.00%
Other shareholders
ZEALAND PHARMA A S shareholders Q4 2019
NameSharesValueWeighting ↓
FARALLON CAPITAL MANAGEMENT LLC 900,000$14,868,0000.09%
WELLINGTON MANAGEMENT GROUP LLP 1,909,983$31,552,0000.01%
MILLENNIUM MANAGEMENT LLC 85,799$1,417,0000.00%
Tower Research Capital LLC (TRC) 1,040$17,0000.00%
UNITED SERVICES AUTOMOBILE ASSOCIATION 23,503$388,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 27,529$455,0000.00%
ROYCE & ASSOCIATES LP 10,000$165,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DEUTSCHE BANK AG\ 13,800$227,0000.00%
MORGAN STANLEY 9,400$155,0000.00%
View complete list of ZEALAND PHARMA A S shareholders